TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biolin Scientific AB
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
78,910
|
77,756
|
67,134 |
Financial expenses |
309
|
177
|
305 |
Earnings before taxes |
13,883
|
10,959
|
9,095 |
EBITDA |
17,387
|
15,221
|
14,140 |
Total assets |
81,468
|
76,216
|
80,638 |
Current assets |
24,308
|
18,657
|
23,577 |
Current liabilities |
18,680
|
19,819
|
15,519 |
Equity capital |
62,237
|
55,841
|
49,535 |
- share capital |
17,762
|
19,328
|
19,701 |
Employees (average) |
21
|
23
|
19 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
76.4%
|
73.3%
|
61.4% |
Turnover per employee |
3,758
|
3,381
|
3,533 |
Profit as a percentage of turnover |
17.6%
|
14.1%
|
13.5% |
Return on assets (ROA) |
17.4%
|
14.6%
|
11.7% |
Current ratio |
130.1%
|
94.1%
|
151.9% |
Return on equity (ROE) |
22.3%
|
19.6%
|
18.4% |
Change turnover |
7,452
|
11,893
|
-17,051 |
Change turnover % |
10%
|
18%
|
-20% |
Chg. No. of employees |
-2
|
4
|
-1 |
Chg. No. of employees % |
-9%
|
21%
|
-5% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.